In such a scenario, deletions in the 9p21.3 cluster involving CDKN2A/ARF/CDKN2B (hereafter CDKN2A/B) genes arise as one of the oncogenic hallmarks of ALL. Here, CDKN2B is linked to acute lymphoblastic leukemia.